Menu
GWAS Study

A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations.

Bønnelykke K, Sleiman P, Nielsen K et al.

24241537 PubMed ID
GWAS Study Type
22225 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BK
Bønnelykke K
SP
Sleiman P
NK
Nielsen K
KE
Kreiner-Møller E
MJ
Mercader JM
BD
Belgrave D
DD
den Dekker HT
HA
Husby A
SA
Sevelsted A
FG
Faura-Tellez G
ML
Mortensen LJ
PL
Paternoster L
FR
Flaaten R
MA
Mølgaard A
SD
Smart DE
TP
Thomsen PF
RM
Rasmussen MA
BS
Bonàs-Guarch S
HC
Holst C
NE
Nohr EA
YR
Yadav R
MM
March ME
BT
Blicher T
LP
Lackie PM
JV
Jaddoe VW
SA
Simpson A
HJ
Holloway JW
DL
Duijts L
CA
Custovic A
DD
Davies DE
TD
Torrents D
GR
Gupta R
HM
Hollegaard MV
HD
Hougaard DM
HH
Hakonarson H
BH
Bisgaard H
Chapter II

Abstract

Summary of the research findings

Asthma exacerbations are among the most frequent causes of hospitalization during childhood, but the underlying mechanisms are poorly understood. We performed a genome-wide association study of a specific asthma phenotype characterized by recurrent, severe exacerbations occurring between 2 and 6 years of age in a total of 1,173 cases and 2,522 controls. Cases were identified from national health registries of hospitalization, and DNA was obtained from the Danish Neonatal Screening Biobank. We identified five loci with genome-wide significant association. Four of these, GSDMB, IL33, RAD50 and IL1RL1, were previously reported as asthma susceptibility loci, but the effect sizes for these loci in our cohort were considerably larger than in the previous genome-wide association studies of asthma. We also obtained strong evidence for a new susceptibility gene, CDHR3 (encoding cadherin-related family member 3), which is highly expressed in airway epithelium. These results demonstrate the strength of applying specific phenotyping in the search for asthma susceptibility genes.

1,173 European ancestry cases, 2,511 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

22225
Total Participants
GWAS
Study Type
Yes
Replicated
395 European ancestry cases, 2,663 European ancestry controls, 63 Turkish, Surinamese, Dutch Antillean, Moroccan, Cape Verdian and other ancestry cases, 917 Turkish, Surinamese, Dutch Antillean, Moroccan, Cape Verdian and other ancestry controls, 6,783 cases, 7,720 controls
Replication Participants
European, NR, Other, Greater Middle Eastern (Middle Eastern, North African or Persian)
Ancestry
Netherlands, Denmark
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.